BFPW
TMO icon

BOK Financial Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

BOK Financial Private Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
3,366
-374
-10% -$180K 0.09% 67
2026
Q1 		$1.84M Sell
3,740
-335
-8% -$182K 0.11% 64
2025
Q4 		$2.36M Sell
4,075
-190
-4% -$107K 0.14% 52
2025
Q3 		$2.07M Sell
4,265
-55
-1% -$25.6K 0.13% 57
2025
Q2 		$1.75M Sell
4,320
-496
-10% -$207K 0.12% 69
2025
Q1 		$2.4M Sell
4,816
-373
-7% -$202K 0.18% 49
2024
Q4 		$2.7M Sell
5,189
-416
-7% -$229K 0.2% 50
2024
Q3 		$3.47M Buy
5,605
+406
+8% +$240K 0.25% 44
2024
Q2 		$2.88M Buy
5,199
+3
+0.1% +$1.72K 0.21% 49
2024
Q1 		$3.02M Sell
5,196
-514
-9% -$288K 0.23% 50
2023
Q4 		$3.03M Sell
5,710
-601
-10% -$291K 0.25% 50
2023
Q3 		$3.2M Sell
6,311
-1,901
-23% -$1.01M 0.28% 47
2023
Q2 		$4.29M Sell
8,212
-970
-11% -$523K 0.35% 43
2023
Q1 		$5.3M Buy
9,182
+346
+4% +$195K 0.43% 34
2022
Q4 		$4.87M Sell
8,836
-492
-5% -$261K 0.4% 38
2022
Q3 		$4.73M Buy
9,328
+769
+9% +$430K 0.43% 34
2022
Q2 		$4.65M Sell
8,559
-1,907
-18% -$1.05M 0.41% 37
2022
Q1 		$6.18M Buy
10,466
+76
+0.7% +$43.7K 0.44% 36
2021
Q4 		$6.93M Buy
10,390
+68
+0.7% +$42.5K 0.48% 37
2021
Q3 		$5.9M Buy
10,322
+203
+2% +$111K 0.47% 34
2021
Q2 		$5.11M Buy
10,119
+330
+3% +$156K 0.42% 42
2021
Q1 		$4.47M Sell
9,789
-214
-2% -$102K 0.41% 42
2020
Q4 		$4.66M Sell
10,003
-261
-3% -$122K 0.44% 42
2020
Q3 		$4.53M Sell
10,264
-732
-7% -$302K 0.47% 41
2020
Q2 		$3.98M Sell
10,996
-3,150
-22% -$1.06M 0.42% 49
2020
Q1 		$4.01M Sell
14,146
-5,456
-28% -$1.72M 0.49% 43
2019
Q4 		$6.37M Buy
+19,602
New +$5.94M 0.54% 50

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BOK Financial Private Wealth's TMO Position: Q2 2026 in Review

BOK Financial Private Wealth reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $180K and leaving 3,366 shares worth $1.69M. The position accounts for 0.09% of the portfolio, ranked #67.

BOK Financial Private Wealth first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $6.93M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • BOK Financial Private Wealth held 3,366 shares of Thermo Fisher Scientific worth $1.69M as of Q2 2026.
  • BOK Financial Private Wealth sold 374 Thermo Fisher Scientific shares in Q2 2026, an estimated $180K.
  • Thermo Fisher Scientific made up 0.09% of BOK Financial Private Wealth's portfolio in Q2 2026, its #67 holding.
  • BOK Financial Private Wealth first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • BOK Financial Private Wealth's Thermo Fisher Scientific position peaked at $6.93M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.